Quay Pharma has been selected by a leading Japanese pharmaceutical company to provide clinical trial drug manufacture of two NCEs. The appointment represents the first time that the Japanese company, which focuses on the development of products to treat diseases in the elderly, has outsourced clinical trials manufacture to a European company. As part of the implementation of the new projects, Quay has purchased additional manufacturing equipment, including a Quadro Comil cone mill and a bespo...